PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

Logo of arthrestherBioMed Centralbiomed central web sitesearchsubmit a manuscriptregisterthis articleArthritis Research & Therapy
 
From:
Published online Jun 7, 2012. doi: 10.1186/ar3868
Table 2
Secondary outcomes (fasting) from study
Median (interquartile range)P-values
0 weeks6 weeks12 weeks0-6 weeks6-12 weeks
Total cholesterol, mg/dL165 (146, 181)166 (130, 178)173 (146, 184)0.180.0002
High density lipoprotein, mg/dL45 (39, 57)48 (3, -57)47 (43, 60)0.950.02
Low density lipoprotein, mg/dL91 (79, 120)83 (70, 102)89 (81, 126)0.150.003
Triglycerides, mg/dL85 (64, 98)75 (52, 116)81(71, 98)0.330.95
C-reactive protein, mg/L2.80 (1.3, 4.6)2.98 (1.7, 3.4)1.91(1.1, 6.3)0.470.96
Fasting insulin, μIU/mL10.44 (6.89, 22.7)9.37 (4.27, 10.26)10.48 (6.87, 17.01)0.090.45
Glucose, mg/dL92 (77, 95)88 (76, 97)86 (80, 97)0.640.72
C-peptide, ng/mL3.81 (2.21, 4.35)3.05 (2.32, 4.20)3.30 (2.15, 4.37)0.490.35
Interleukin-6, pg/mL2.90 (2.15, 3.92)3.06 (2.13, 3.84)3.12 (2.64, 4.03)0.810.62
Articles from Arthritis Research & Therapy are provided here courtesy of
BioMed Central